Carson Wealth (CWM LLC)
INFI

Carson Wealth (CWM LLC)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-323
Closed – – 4441
2022
Q4 		$0 Buy
+323
New +$275 ﹤0.01% 4349

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carson Wealth (CWM LLC)'s INFI Position: Q1 2023 in Review

Carson Wealth (CWM LLC) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2023, closing a stake of 323 shares.

Carson Wealth (CWM LLC) first reported a position in INFI in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 53 funds tracked by Wall St. Rank hold INFI as of Q1 2023.

  • Carson Wealth (CWM LLC) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 323 Infinity Pharmaceuticals, Inc. shares in Q1 2023.
  • Carson Wealth (CWM LLC) first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Carson Wealth (CWM LLC)'s Infinity Pharmaceuticals, Inc. position peaked at $0 in Q4 2022.
  • 53 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2023, filed 1 May 2023.